This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dechecchi, M. C.
Right arrow Articles by Cabrini, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dechecchi, M. C.
Right arrow Articles by Cabrini, G.

 Previous Article  |  Next Article 

Journal of Virology, September 2001, p. 8772-8780, Vol. 75, No. 18
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.18.8772-8780.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Heparan Sulfate Glycosaminoglycans Are Receptors Sufficient To Mediate the Initial Binding of Adenovirus Types 2 and 5

M. C. Dechecchi,1 P. Melotti,1 A. Bonizzato,1 M. Santacatterina,2 M. Chilosi,2 and G. Cabrini1,*

Laboratory of Molecular Pathology, Cystic Fibrosis Center,1 and Department of Pathology, University of Verona,2 Verona, Italy

Received 15 February 2001/Accepted 9 April 2001

Cell infection by adenovirus serotypes 2 and 5 (Ad2/5) initiates with the attachment of Ad fiber to the coxsackievirus and Ad receptor (CAR) followed by alpha v integrin-mediated entry. We recently demonstrated that heparan sulfate glycosaminoglycans (HS GAGs) expressed on cell surfaces are involved in the binding and infection of Ad2/5 (M. C. Dechecchi, A. Tamanini, A. Bonizzato, and G. Cabrini, Virology 268:382-390, 2000). The role of HS GAGs was investigated using extracellular soluble domain 1 of CAR (sCAR-D1) and heparin as soluble receptor analogues of CAR and HS GAGs in A549 and recombinant CHO cell lines with differential levels of expression of the two receptors and cultured to various densities. Complete inhibition of binding and infection was obtained by preincubating Ad2/5 with both heparin (10 µg/ml) and sCAR-D1 (200 µg/ml) in A549 cells. Partial inhibition was observed when heparin and sCAR-D1 were preincubated separately with Ad. The level of heparin-sensitive [3H]Ad2/5 binding doubled in sparse A549 cells (50 to 70,000 cells/cm2) with respect to that of cells grown to confluence (200 to 300,000 cells/cm2), in parallel with increased expression of HS GAGs. [3H]Ad2 bound to sparse CAR-negative CHO cells expressing HS GAGs (CHO K1). No [3H]Ad2 binding was observed in CHO K1 cells upon competitive inhibition with heparin and in HS GAG-defective CHO A745, D677, and E606 clones. HS-sensitive Ad2 infection was obtained in CAR-negative sparse CHO K1 cells but not in CHO A745 cells, which were permissive to infection only upon transfection with CAR. These results demonstrate that HS GAGs are sufficient to mediate the initial binding of Ad2/5.


* Corresponding author. Mailing address: Laboratorio Patologia Molecolare, Centro Regionale Fibrosi Cistica, Piazzale Stefani, 1, 37126 Verona, Italy. Phone: 39-045-807 2364. Fax: 39-045-807 2840. E-mail: cabrini{at}linus.univr.it.


Journal of Virology, September 2001, p. 8772-8780, Vol. 75, No. 18
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.18.8772-8780.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Darr, S., Madisch, I., Hofmayer, S., Rehren, F., Heim, A. (2009). Phylogeny and primary structure analysis of fiber shafts of all human adenovirus types for rational design of adenoviral gene-therapy vectors. J. Gen. Virol. 90: 2849-2854 [Abstract] [Full Text]  
  • Alba, R., Bradshaw, A. C., Parker, A. L., Bhella, D., Waddington, S. N., Nicklin, S. A., van Rooijen, N., Custers, J., Goudsmit, J., Barouch, D. H., McVey, J. H., Baker, A. H. (2009). Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114: 965-971 [Abstract] [Full Text]  
  • Adams, W. C., Bond, E., Havenga, M. J. E., Holterman, L., Goudsmit, J., Karlsson Hedestam, G. B., Koup, R. A., Lore, K. (2009). Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN. J. Gen. Virol. 90: 1600-1610 [Abstract] [Full Text]  
  • Granio, O., Porcherot, M., Corjon, S., Kitidee, K., Henning, P., Eljaafari, A., Cimarelli, A., Lindholm, L., Miossec, P., Boulanger, P., Hong, S.-S. (2009). Improved Adenovirus Type 5 Vector-Mediated Transduction of Resistant Cells by Piggybacking on Coxsackie B-Adenovirus Receptor-Pseudotyped Baculovirus. J. Virol. 83: 6048-6066 [Abstract] [Full Text]  
  • Jonsson, M. I., Lenman, A. E., Frangsmyr, L., Nyberg, C., Abdullahi, M., Arnberg, N. (2009). Coagulation Factors IX and X Enhance Binding and Infection of Adenovirus Types 5 and 31 in Human Epithelial Cells. J. Virol. 83: 3816-3825 [Abstract] [Full Text]  
  • Robinson, M., Li, B., Ge, Y., Ko, D., Yendluri, S., Harding, T., VanRoey, M., Spindler, K. R., Jooss, K. (2009). Novel Immunocompetent Murine Tumor Model for Evaluation of Conditionally Replication-Competent (Oncolytic) Murine Adenoviral Vectors. J. Virol. 83: 3450-3462 [Abstract] [Full Text]  
  • Raman, S., Hsu, T.-H., Ashley, S. L., Spindler, K. R. (2009). Usage of Integrin and Heparan Sulfate as Receptors for Mouse Adenovirus Type 1. J. Virol. 83: 2831-2838 [Abstract] [Full Text]  
  • Russell, W. C. (2009). Adenoviruses: update on structure and function. J. Gen. Virol. 90: 1-20 [Abstract] [Full Text]  
  • Peerlinck, I., Amini-Nik, S., Phillips, R. K., Iggo, R., Lemoine, N. R., Tejpar, S., Vassaux, G. (2008). Therapeutic Potential of Replication-Selective Oncolytic Adenoviruses on Cells from Familial and Sporadic Desmoid Tumors. Clin. Cancer Res. 14: 6187-6192 [Abstract] [Full Text]  
  • Singh, R., Tian, B., Kostarelos, K. (2008). Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo. FASEB J. 22: 3389-3402 [Abstract] [Full Text]  
  • Di Paolo, N. C., Kalyuzhniy, O., Shayakhmetov, D. M. (2007). Fiber Shaft-Chimeric Adenovirus Vectors Lacking the KKTK Motif Efficiently Infect Liver Cells In Vivo. J. Virol. 81: 12249-12259 [Abstract] [Full Text]  
  • Xie, J., Chiang, L., Contreras, J., Wu, K., Garner, J. A., Medina-Kauwe, L., Hamm-Alvarez, S. F. (2006). Novel Fiber-Dependent Entry Mechanism for Adenovirus Serotype 5 in Lacrimal Acini. J. Virol. 80: 11833-11851 [Abstract] [Full Text]  
  • Tamanini, A., Nicolis, E., Bonizzato, A., Bezzerri, V., Melotti, P., Assael, B. M., Cabrini, G. (2006). Interaction of Adenovirus Type 5 Fiber with the Coxsackievirus and Adenovirus Receptor Activates Inflammatory Response in Human Respiratory Cells. J. Virol. 80: 11241-11254 [Abstract] [Full Text]  
  • Schoggins, J. W., Falck-Pedersen, E. (2006). Fiber and Penton Base Capsid Modifications Yield Diminished Adenovirus Type 5 Transduction and Proinflammatory Gene Expression with Retention of Antigen-Specific Humoral Immunity. J. Virol. 80: 10634-10644 [Abstract] [Full Text]  
  • Bayo-Puxan, N., Cascallo, M., Gros, A., Huch, M., Fillat, C., Alemany, R. (2006). Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting. J. Gen. Virol. 87: 2487-2495 [Abstract] [Full Text]  
  • Lecollinet, S., Gavard, F., Havenga, M. J. E., Spiller, O. B., Lemckert, A., Goudsmit, J., Eloit, M., Richardson, J. (2006). Improved Gene Delivery to Intestinal Mucosa by Adenoviral Vectors Bearing Subgroup B and D Fibers. J. Virol. 80: 2747-2759 [Abstract] [Full Text]  
  • Xiong, Z., Cheng, Z., Zhang, X., Patel, M., Wu, J. C., Gambhir, S. S., Chen, X. (2006). Imaging Chemically Modified Adenovirus for Targeting Tumors Expressing Integrin {alpha}v{beta}3 in Living Mice with Mutant Herpes Simplex Virus Type 1 Thymidine Kinase PET Reporter Gene. JNM 47: 130-139 [Abstract] [Full Text]  
  • Toh, M.-L., Hong, S.-S., Loo, F. v. d., Franqueville, L., Lindholm, L., Berg, W. v. d., Boulanger, P., Miossec, P. (2005). Enhancement of Adenovirus-Mediated Gene Delivery to Rheumatoid Arthritis Synoviocytes and Synovium by Fiber Modifications: Role of Arginine-Glycine-Aspartic Acid (RGD)- and Non-RGD-Binding Integrins. J. Immunol. 175: 7687-7698 [Abstract] [Full Text]  
  • Marttila, M., Persson, D., Gustafsson, D., Liszewski, M. K., Atkinson, J. P., Wadell, G., Arnberg, N. (2005). CD46 Is a Cellular Receptor for All Species B Adenoviruses except Types 3 and 7. J. Virol. 79: 14429-14436 [Abstract] [Full Text]  
  • Zhang, Y., Bergelson, J. M. (2005). Adenovirus Receptors. J. Virol. 79: 12125-12131 [Full Text]  
  • Schoggins, J. W., Nociari, M., Philpott, N., Falck-Pedersen, E. (2005). Influence of Fiber Detargeting on Adenovirus-Mediated Innate and Adaptive Immune Activation. J. Virol. 79: 11627-11637 [Abstract] [Full Text]  
  • Zhang, L., Bukreyev, A., Thompson, C. I., Watson, B., Peeples, M. E., Collins, P. L., Pickles, R. J. (2005). Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway Epithelium. J. Virol. 79: 1113-1124 [Abstract] [Full Text]  
  • Wang, Y., Thorne, S., Hannock, J., Francis, J., Au, T., Reid, T., Lemoine, N., Kirn, D., Hallden, G. (2005). A Novel Assay to Assess Primary Human Cancer Infectibility by Replication-Selective Oncolytic Adenoviruses. Clin. Cancer Res. 11: 351-360 [Abstract] [Full Text]  
  • Skog, J., Edlund, K., Widegren, B., Salford, L. G., Wadell, G., Mei, Y.-F. (2004). Efficient internalization into low-passage glioma cell lines using adenoviruses other than type 5: an approach for improvement of gene delivery to brain tumours. J. Gen. Virol. 85: 2627-2638 [Abstract] [Full Text]  
  • Gaden, F., Franqueville, L., Magnusson, M. K., Hong, S. S., Merten, M. D., Lindholm, L., Boulanger, P. (2004). Gene Transduction and Cell Entry Pathway of Fiber-Modified Adenovirus Type 5 Vectors Carrying Novel Endocytic Peptide Ligands Selected on Human Tracheal Glandular Cells. J. Virol. 78: 7227-7247 [Abstract] [Full Text]  
  • Pietrantoni, A., Di Biase, A. M., Tinari, A., Marchetti, M., Valenti, P., Seganti, L., Superti, F. (2003). Bovine Lactoferrin Inhibits Adenovirus Infection by Interacting with Viral Structural Polypeptides. Antimicrob. Agents Chemother. 47: 2688-2691 [Abstract] [Full Text]  
  • Okuma, K., Dalton, K. P., Buonocore, L., Ramsburg, E., Rose, J. K. (2003). Development of a Novel Surrogate Virus for Human T-Cell Leukemia Virus Type 1: Inhibition of Infection by Osteoprotegerin. J. Virol. 77: 8562-8569 [Abstract] [Full Text]  
  • Weigele, P. R., Scanlon, E., King, J. (2003). Homotrimeric, {beta}-Stranded Viral Adhesins and Tail Proteins. J. Bacteriol. 185: 4022-4030 [Full Text]  
  • Noya, F., Balague, C., Banerjee, N. S., Curiel, D. T., Broker, T. R., Chow, L. T. (2003). Activation of Adenovirus Early Promoters and Lytic Phase in Differentiated Strata of Organotypic Cultures of Human Keratinocytes. J. Virol. 77: 6533-6540 [Abstract] [Full Text]  
  • Schoggins, J. W., Gall, J. G. D., Falck-Pedersen, E. (2002). Subgroup B and F Fiber Chimeras Eliminate Normal Adenovirus Type 5 Vector Transduction In Vitro and In Vivo. J. Virol. 77: 1039-1048 [Abstract] [Full Text]  
  • El-Sheikh, A., Liu, C., Huang, H., Edgington, T. S. (2002). A Novel Vascular Endothelial Growth Factor Heparin-binding Domain Substructure Binds to Glycosaminoglycans in Vivo and Localizes to Tumor Microvascular Endothelium. Cancer Res. 62: 7118-7123 [Abstract] [Full Text]  
  • Gaden, F., Franqueville, L., Hong, S. S., Legrand, V., Figarella, C., Boulanger, P. (2002). Mechanism of Restriction of Normal and Cystic Fibrosis Transmembrane Conductance Regulator-Deficient Human Tracheal Gland Cells to Adenovirus Infection and Ad-Mediated Gene Transfer. Am. J. Respir. Cell Mol. Bio. 27: 628-640 [Abstract] [Full Text]  
  • Iqbal, M., McCauley, J. W. (2002). Identification of the glycosaminoglycan-binding site on the glycoprotein Erns of bovine viral diarrhoea virus by site-directed mutagenesis. J. Gen. Virol. 83: 2153-2159 [Abstract] [Full Text]  
  • Lei, P., Bajaj, B., Andreadis, S. T. (2002). Retrovirus-Associated Heparan Sulfate Mediates Immobilization and Gene Transfer on Recombinant Fibronectin. J. Virol. 76: 8722-8728 [Abstract] [Full Text]  
  • Arnberg, N., Pring-Akerblom, P., Wadell, G. (2002). Adenovirus Type 37 Uses Sialic Acid as a Cellular Receptor on Chang C Cells. J. Virol. 76: 8834-8841 [Abstract] [Full Text]  
  • Hasenburg, A., Fischer, D.-C., Tong, X.-W., Rojas-Martinez, A., Kaufman, R. H., Ramzy, I., Kohlberger, P., Orlowska-Volk, M., Aguilar-Cordova, E., Kieback, D. G. (2002). Adenovirus-Mediated Thymidine Kinase Gene Therapy for Recurrent Ovarian Cancer: Expression of Coxsackie-Adenovirus Receptor and Integrins {alpha}v{beta}3 and {alpha}v{beta}5. Reproductive Sciences 9: 174-180 [Abstract]  
  • Kanerva, A., Mikheeva, G. V., Krasnykh, V., Coolidge, C. J., Lam, J. T., Mahasreshti, P. J., Barker, S. D., Straughn, M., Barnes, M. N., Alvarez, R. D., Hemminki, A., Curiel, D. T. (2002). Targeting Adenovirus to the Serotype 3 Receptor Increases Gene Transfer Efficiency to Ovarian Cancer Cells. Clin. Cancer Res. 8: 275-280 [Abstract] [Full Text]